Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


JPMA Establishes Work Group To Consider Information Disclosure Rule

This article was originally published in PharmAsia News

Executive Summary

The Japanese Pharmaceutical Manufacturer's Association June 17 established a work group to discuss rules for disclosing funds provided to medical researchers from drug companies. The association hopes to gather information from overseas and decide on the range and scope of such financial provisions and establish industry-wide policy guidance. JPMA aims to summarize various opinions by the fall. The financial information disclosure guidance intends to address fairness and objectivity issues regarding medical researchers. An April survey conducted by Yomiuri Shimbun of the JMPA's 69 members found that only 10 percent expressed their willingness to disclose the information. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts